Skip to main content
Clinical Trials/TCTR20200305002
TCTR20200305002Active, not recruiting未知

Responsiveness of Mini-Balance Evaluation System Test (Mini-BESTest) in Type II Diabetic Patients with Peripheral Neuropathy

/A0 sites48 target enrollmentStarted: March 5, 2020Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Active, not recruiting
Sponsor
Enrollment
48

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
40 Years to 70 Years (—)
Sex
All

Inclusion Criteria

  • 1) Patients aged between 40 †70 years
  • 2) Diagnosis as type 2 diabetes with well-controlled blood glucose based on follow up three times of medical assessments according to medical records
  • 3) Screened with Michigan Neuropathy Screening Instrument (MNSI) and have a MNSI score ≥ 2.5 out of 10 by the researcher (Herman et al. 2012)
  • 4) Diabetic duration of more than 5 years according to the medical record
  • 5) Able to understand the instructions by mini-mental state examination (MMSE ) (Roman de Mettelinge et al., 2013)

Exclusion Criteria

  • 1) Diagnosis as peripheral venous insufficiency, cardiac, renal or hepatic insufficiency, uncontrolled hypertension or myopathic by medical record
  • 2) Diagnosis as central nervous system dysfunction (such as stroke, Parkinson’s disease, and cerebral ataxia) by medical record
  • 3) Foot ulcers by physical examination
  • 4) Fracture of the lower limbs within the 6 months before the study by physical examination
  • 5) Partial or complete blindness by physical examination
  • 6) Severe auditory problems by physical examination (Chatchawan, Eungpinichpong, Plandee, & Yamauchi, 2015) (Marques et al. 2017)

Investigators

Sponsor
/A

Similar Trials